Dr. Samvel Bardakhchyan, the Lead of the Adult Oncology task force has received Harvard certification on the subject of “HMX Pro- Immunology and Immuno-Oncology”. Advances in knowledge of the immune system are changing the ways in which we treat various types of cancer and this course highlights this.
Understanding how immune cells recognize and kill cancer cells, and what we can do to enhance their ability to fight cancer, is important for anyone working to develop new cancer treatments or apply them in the clinic. We congratulate our Scientific Director for completing this unique online course designed to help professionals learn about cutting-edge cancer immunotherapies from leading Harvard Medical School faculty.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.